Literature DB >> 7706950

Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor.

C A Dyer1, D P Cistola, G C Parry, L K Curtiss.   

Abstract

Apolipoprotein (apo) E, via its receptor binding domain contained in residues 140-150, mediates hepatic and peripheral tissue binding of cholesterol-rich lipoproteins. Previously, we reported that a synthetic peptide representing a linear tandem repeat of amino acids 141-155, the 141-155 dimer, binds the low density lipoprotein (LDL) receptor. To define the structural features essential for LDL receptor binding of the 141-155 dimer, a series of modified peptides were synthesized. The secondary structure content of the modified apoE peptides was assessed by circular dichroism (CD) and the receptor activity was studied in cellular LDL receptor binding assays. alpha-Helix content was necessary but not sufficient for receptor activity because both a 129-162 monomer and the 141-155 dimer peptides had comparable CD spectra and helix contents, but only the 141-155 dimer was receptor active. Deletion of the charged amino terminal residues including arg142 and lys143 in the 145-155 or 144-150 dimers had no effect on alpha-helix content, yet abolished their receptor activities. Helical net models of all receptor active peptides indicated that the LDL-receptor binding activity of the 141-155 dimer is dependent on at least two clusters of basic amino acids present on the hydrophilic face of the amphipathic alpha-helix of the 141-155, 141-150, 141-155 (lys143-->ala) and 141-155 (arg150-->ala) dimer peptides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706950

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

Review 3.  Design of growth factor sequestering biomaterials.

Authors:  David G Belair; Ngoc Nhi Le; William L Murphy
Journal:  Chem Commun (Camb)       Date:  2014-09-03       Impact factor: 6.222

4.  NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles.

Authors:  D Clayton; I M Brereton; P A Kroon; R Smith
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

5.  Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.

Authors:  Jin Kim; Theodore Smith; Neeraja Idamakanti; Kathy Mulgrew; Michele Kaloss; Helen Kylefjord; Patricia C Ryan; Michael Kaleko; Susan C Stevenson
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice.

Authors:  Vishal Singh; Manish Kumar; Beng San Yeoh; Xia Xiao; Piu Saha; Mary J Kennett; Matam Vijay-Kumar
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

7.  An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.

Authors:  I R Nikoulin; L K Curtiss
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

Authors:  Yann Le Guen; Michael E Belloy; Benjamin Grenier-Boley; Itziar de Rojas; Atahualpa Castillo-Morales; Iris Jansen; Aude Nicolas; Céline Bellenguez; Carolina Dalmasso; Fahri Küçükali; Sarah J Eger; Katrine Laura Rasmussen; Jesper Qvist Thomassen; Jean-François Deleuze; Zihuai He; Valerio Napolioni; Philippe Amouyel; Frank Jessen; Patrick G Kehoe; Cornelia van Duijn; Magda Tsolaki; Pascual Sánchez-Juan; Kristel Sleegers; Martin Ingelsson; Giacomina Rossi; Mikko Hiltunen; Rebecca Sims; Wiesje M van der Flier; Alfredo Ramirez; Ole A Andreassen; Ruth Frikke-Schmidt; Julie Williams; Agustín Ruiz; Jean-Charles Lambert; Michael D Greicius; Beatrice Arosio; Luisa Benussi; Anne Boland; Barbara Borroni; Paolo Caffarra; Delphine Daian; Antonio Daniele; Stéphanie Debette; Carole Dufouil; Emrah Düzel; Daniela Galimberti; Vilmantas Giedraitis; Timo Grimmer; Caroline Graff; Edna Grünblatt; Olivier Hanon; Lucrezia Hausner; Stefanie Heilmann-Heimbach; Henne Holstege; Jakub Hort; Deckert Jürgen; Teemu Kuulasmaa; Aad van der Lugt; Carlo Masullo; Patrizia Mecocci; Shima Mehrabian; Alexandre de Mendonça; Susanne Moebus; Benedetta Nacmias; Gael Nicolas; Robert Olaso; Goran Papenberg; Lucilla Parnetti; Florence Pasquier; Oliver Peters; Yolande A L Pijnenburg; Julius Popp; Innocenzo Rainero; Inez Ramakers; Steffi Riedel-Heller; Nikolaos Scarmeas; Philip Scheltens; Norbert Scherbaum; Anja Schneider; Davide Seripa; Hilkka Soininen; Vincenzo Solfrizzi; Gianfranco Spalletta; Alessio Squassina; John van Swieten; Thomas J Tegos; Lucio Tremolizzo; Frans Verhey; Martin Vyhnalek; Jens Wiltfang; Mercè Boada; Pablo García-González; Raquel Puerta; Luis M Real; Victoria Álvarez; María J Bullido; Jordi Clarimon; José María García-Alberca; Pablo Mir; Fermin Moreno; Pau Pastor; Gerard Piñol-Ripoll; Laura Molina-Porcel; Jordi Pérez-Tur; Eloy Rodríguez-Rodríguez; Jose Luís Royo; Raquel Sánchez-Valle; Martin Dichgans; Dan Rujescu
Journal:  JAMA Neurol       Date:  2022-07-01       Impact factor: 29.907

9.  Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry.

Authors:  Juan Guevara; Jamie Romo; Troy McWhorter; Natalia Valentinova Guevara
Journal:  J Viruses       Date:  2015

10.  Parallel synthesis of cell-penetrating peptide conjugates of PMO toward exon skipping enhancement in Duchenne muscular dystrophy.

Authors:  Liz O'Donovan; Itaru Okamoto; Andrey A Arzumanov; Donna L Williams; Peter Deuss; Michael J Gait
Journal:  Nucleic Acid Ther       Date:  2014-11-20       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.